Anti-IL17REL monoclonal antibody

Pre-made anti-IL17REL monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to IL17REL/IL17REL products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2890-Ab-1/ GM-Tg-hg-IP2890-Ab-2Anti-Human IL17REL monoclonal antibodyHuman
GM-Tg-rg-IP2890-Ab-1/ GM-Tg-rg-IP2890-Ab-2Anti-Rat IL17REL monoclonal antibodyRat
GM-Tg-mg-IP2890-Ab-1/ GM-Tg-mg-IP2890-Ab-2Anti-Mouse IL17REL monoclonal antibodyMouse
GM-Tg-cynog-IP2890-Ab-1/ GM-Tg-cynog-IP2890-Ab-2Anti-Cynomolgus/ Rhesus macaque IL17REL monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2890-Ab-1/ GM-Tg-felg-IP2890-Ab-2Anti-Feline IL17REL monoclonal antibodyFeline
GM-Tg-cang-IP2890-Ab-1/ GM-Tg-cang-IP2890-Ab-2Anti-Canine IL17REL monoclonal antibodyCanine
GM-Tg-bovg-IP2890-Ab-1/ GM-Tg-bovg-IP2890-Ab-2Anti-Bovine IL17REL monoclonal antibodyBovine
GM-Tg-equg-IP2890-Ab-1/ GM-Tg-equg-IP2890-Ab-2Anti-Equine IL17REL monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2890-Ab-1/ GM-Tg-hg-IP2890-Ab-2; GM-Tg-rg-IP2890-Ab-1/ GM-Tg-rg-IP2890-Ab-2;
GM-Tg-mg-IP2890-Ab-1/ GM-Tg-mg-IP2890-Ab-2; GM-Tg-cynog-IP2890-Ab-1/ GM-Tg-cynog-IP2890-Ab-2;
GM-Tg-felg-IP2890-Ab-1/ GM-Tg-felg-IP2890-Ab-2; GM-Tg-cang-IP2890-Ab-1/ GM-Tg-cang-IP2890-Ab-2;
GM-Tg-bovg-IP2890-Ab-1/ GM-Tg-bovg-IP2890-Ab-2; GM-Tg-equg-IP2890-Ab-1/ GM-Tg-equg-IP2890-Ab-2
Products NameAnti-IL17REL monoclonal antibody
Formatmab
Target NameIL17REL
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-IL17REL monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2890-Ag-1Recombinant multi-species I17EL/ IL17REL protein


    Target information

    Target IDGM-IP2890
    Target NameIL17REL
    Gene ID400935,715316,607159,101100574,100336471,100054843
    Gene Symbol and SynonymsIL17REL
    Uniprot AccessionQ6ZVW7
    Uniprot Entry NameI17EL_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000188263
    Target ClassificationN/A

    The target: IL17REL, gene name: IL17REL, also named as . Predicted to enable interleukin-17 receptor activity. Predicted to be involved in cytokine-mediated signaling pathway. .



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.